Antiangiogenic drug to treat cancer, arthritis and retinopathy

Details Antiangiogenic drug to treat cancer, arthritis and retinopathy Antiangiogenic drug to treat cancer, arthritis and retinopathy

1998-03-16

1999-08-03

Davenport, Avis M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530326, 530327, 530328, 514 13, 514 14, 514 15, 514 16, A61K 3800

Patent

active

059325453

ABSTRACT:
Peptides having the formula:

REFERENCES:
Journal of Peptide Research, vol. 50, No. 3 (Sep. 1997), pp. 210-221, Guo et al., "Antiproliferative and Antitumor Activities of D-Reverse Peptides Derived from the Second Type-1 Repeat of Thrombospondin-1".

Affiliated with

Also associated with

Rating

Antiangiogenic drug to treat cancer, arthritis and retinopathy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiangiogenic drug to treat cancer, arthritis and retinopathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiangiogenic drug to treat cancer, arthritis and retinopathy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-849452